Tatiana P. Kalashnikova

Tatiana P. Kalashnikova

Auto-generated profile, based on publicly available information

Tatiana P. Kalashnikova

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Pulmonology
Verified
Journal Article
Open access
TKTatiana P. Kalashnikova
Tatiana P. Kalashnikova
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
YAYulia A. Arsenyeva
Yulia A. Arsenyeva
YPYuri K. Podoksenov
Yuri K. Podoksenov
IKIgor Kravchenko
Igor Kravchenko
ABAlla A. Boshchenko
Alla A. Boshchenko
This study aimed to assess the safety and potential efficacy of high-dose inhaled nitric oxide therapy for the prevention of postoperative pneumonia in cardiac surgery patients. A prospective randomised controlled pilot study included 74 patients with moderate risk of postoperative pneumonia after elective cardiac surgery under cardiopulmonary bypass. Patients were randomised into two groups. The main group (NO-group) (n = 37) received inhaled nitric oxide at a dose of 200 ppm for 30 minutes 2 times a day for 5 days or until pneumonia developed. The control group received conventional postoperative care (n = 37). The primary endpoint was the incidence of postoperative pneumonia during in-hospital stay. Preventive nitric oxide inhalations were associated with a reduced incidence of postoperative nosocomial pneumonia (2 (5.4%) cases in the main group (NO-group) vs. 9 (24.3%) cases in the control group, p = 0.046; OR = 0.178, 95% CI = 0.036-0.89)). There was no decrease in either peak expiratory flow, or peak inspiratory flow in comparison with the preoperative values in the NO-group. Inhaled nitric oxide therapy is safe. It did not lead to an increase in the incidence of acute kidney injury. High-dose inhaled nitric oxide therapy is safe and effective for the prevention of postoperative nosocomial pneumonia in cardiac surgery.

18 January 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
MKMikhail S. Kuznetsov
Mikhail S. Kuznetsov
MDMaria Diakova
Maria Diakova
YPYu. K. Podoksenov
Yu. K. Podoksenov
TKT. P. Kalashnikova
T. P. Kalashnikova
BKBoris Kozlov
Boris Kozlov
The article describes a clinical case of inhalation therapy with high doses of nitric oxide (NO) in a comorbid patient with a severe course of COVID-19. An air stream containing NO was generated using the PLAZON device. High-dose NO inhalation therapy was administered as a life-saving option due to the lack of effect from treatment delivered in accordance with the current national clinical guidelines for the treatment of COVID-19. The safety and clinical efficacy of the technique was demonstrated.

8 November 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
IKIgor Kravchenko
Igor Kravchenko
YPYu.K. Podoksenov
Yu.K. Podoksenov
TMTyo Mark
Tyo Mark
TKT.P. Kalashnikova
T.P. Kalashnikova
ECElena Churilina
Elena Churilina
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
Introduction: Organoprotective effects of perioperative nitric oxide delivery towards the heart and kidneys have been demonstrated many times in cardiac surgery but information about its ability to prevent respiratory complications is extremely limited. Objective: This study aimed at evaluation of the efficacy and the safety of perioperative nitric oxide delivery for preventing respiratory complications during cardiac surgeries involving cardiopulmonary bypass in patients with an increased risk of adverse respiratory events and the identification of the risk factors towards postoperative acute respiratory. Methods: A prospective randomised controlled study included 132 cardiac surgical patients with increased risk of postoperative respiratory failure who were divided into two groups. The main group received nitric oxide at a concentration of 80 ppm throughout the operation and the first 6 hours at the postoperative period. The primary endpoint was the ratio of the partial pressure of oxygen in arterial blood to the fraction of inspired oxygen in 24 hours after the operation. Results: Patients receiving perioperative nitric oxide demonstrated significant improvements in oxygenation (paO2/FiO2 ratio, p < 0.001) in 24 hour post-surgery period that was associated with a decrease in pulmonary shunt fraction (p < 0.001), a decline of acute respiratory failure incidence (p = 0.042), and postoperative pneumonia (p = 0.013). Delivery of nitric oxide did not entail an increase in methemoglobin concentration above 5% and nitrogen dioxide above 3 ppm. In 24 h after surgery, revealed cases of acute respiratory failure were associated with blood transfusion (p = 0.033), as well as an excess of cardiopulmonary bypass duration of more than 97 min and mechanical ventilator duration of more than 628 min. Conclusion: Perioperative delivery of 80 ppm nitric oxide in cardiac surgeries involving cardiopulmonary bypass is safe and effective since it results in improved pulmonary oxygenating function and decreased pulmonary complications. In patients with an increased risk of adverse respiratory events, identified risk factors of acute respiratory failure include blood transfusion, prolonged cardiopulmonary bypass, and extended mechanical ventilation. Received 23 September 2024. Revised 2 October 2024. Accepted 7 October 2024. FundingThe study was carried out within the framework of the state assignment under the topic of basic scientific research No. 122123000017-3. Conflict of interestsThe authors declare no conflict of interest. Contribution of the authorsConception and study design: N.O. Kamenshchikov, I.V. Kravchenko, Yu.K. Podoksenov, B.N. KozlovData collection and analysis: I.V. Kravchenko, M.A. Tyo, E.A. Churilina, M.S. Kozulin, A.M. Gusakova, T.P. KalashnikovaStatistical analysis: I.V. Kravchenko, Yu.K. PodoksenovDrafting the article: I.V. Kravchenko, Yu.K. PodoksenovCritical revision of the article: N.O. Kamenshchikov, B.N. KozlovFinal approval of the version to be published: I.V. Kravchenko, Yu.K. Podoksenov, M.A. Tyo, T.P. Kalashnikova, E.A. Churilina, M.S. Kozulin, A.M. Gusakova, B.N. Kozlov, N.O. Kamenshchikov

25 December 2023 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
TKTatyana P. Kalashnikova
Tatyana P. Kalashnikova
YAYulia A. Arsenyeva
Yulia A. Arsenyeva
МГМария Борисовна Горчакова
Мария Борисовна Горчакова
IKIgor Kravchenko
Igor Kravchenko
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
НКНиколай Олегович Каменщиков
Николай Олегович Каменщиков
HighlightsFor the first time, the incidence and timing of the development of postoperative pneumonia in patients undergoing surgical reconstruction of the aortic arch in the post-covid period were studied. Risk factors for pneumonia and predictors of the severe course of the disease in this cohort of patients were identified. The results obtained will make it possible to differentiate patients at risk of developing pneumonia from the general population of patients undergoing surgical reconstruction of the aortic arch for targeted perioperative prevention of this complication. AbstractAim. To study the incidence of nosocomial pneumonia (NP) after aortic arch surgery, and to determine the impact of perioperative factors on the risk for its development and severity of its course.Methods. A retrospective analysis of 66 case histories of patients who underwent aortic arch surgery in 2022 was carried out. The incidence and timing of the development of pneumonia were revealed, the severity of its course was assessed. The impact of the main demographic, clinical, perioperative factors on the risk for the pneumonia development and the severity of its course was studied.Results. The incidence of pneumonia after aortic arch surgery was 24.2%. A relationship between smoking (OR 1.17; 95% CI [0.23; 1.43], p = 0.007), smoking index (OR 0.99; 95% CI [0.92; 1.07], p = 0.002) and the risk of NP developing as well as between the duration of mechanical ventilation and the severity of NP was found with a univariate logistic regression analysis (OR 1.26; 95% CI [1.0; 1.59], p = 0.049).Conclusion. The risk for NP development in patients who underwent thoracic aortic surgery is associated with smoking and smoking intensity in the preoperative period. The predictor of the severe course of NP is the duration of mechanical ventilation.

8 February 2025 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
TKT. P. Kalashnikova
T. P. Kalashnikova
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
YPYu. K. Podoksenov
Yu. K. Podoksenov
YAYu. A. Arseneva
Yu. A. Arseneva
TMTyo Mark
Tyo Mark
ABAlla Boshchenko
Alla Boshchenko
Nosocomial pneumonia is the most common infectious complication following cardiac surgical procedures. The aim was to assess the efficacy and safety of repeated inhalation sessions of 200 ppm nitric oxide for nosocomial pneumonia following cardiac surgical procedures. Methods. The pilot single-center prospective randomized study included spontaneously breathing patients with cardiovascular diseases, operated on under artificial circulation, with a complicated postoperative period in the form of nosocomial pneumonia. These patients (n = 40) underwent surgical procedures under cardiopulmonary bypass and developed nosocomial pneumonia in the postoperative period. The control group (n = 20) received standard antibacterial therapy, the experimental group (n = 20) received additional inhalation of 200 ppm nitric oxide (iNO) for 30 minutes 3 times a day before the completion of antibacterial therapy, but no more than 7 days later. We assessed the duration of antibacterial therapy, the changes in temperature, blood pressure, respiratory rate and heart rate, the oxygenation index SpO2/FiO2 and PO2/FiO2, the level of leukocytes, C-reactive protein, procalcitonin, presepsin, ferritin, and the quality of life questionnaire EQ-5D-5L score. The frequency of changes in antibacterial therapy regimens due to their ineffectiveness and the duration of hospitalization were compared. Results. iNO therapy was well tolerated, did not have a significant effect on systemic hemodynamics, and was not accompanied by a clinically significant increase in the level of methemoglobin and NO2. Its duration was 6.2 ± 0.8 days. In the iNO treatment group, there was a shorter time of antibacterial therapy (p < 0.001), a shorter duration of fever (p = 0,008), and a shorter frequency of changing antibacterial treatment regimens due to their ineffectiveness (p < 0,001). Under the influence of iNO, higher rates of oxygenation indices SpO2/FiO2 were noted on Day 3 (p = 0,034) and on the day of completion of antibacterial therapy (p = 0,009); higher PO2/FiO2 were observed on Day 3 (p = 0,002), Day 5 (p < 0,001) of the therapy and the day of the completion of antibacterial therapy (p = 0,004). In the iNO treatment group, a decrease in the level of leukocytes, procalcitonin, and the neutrophil-to-lymphocyte ratio was detected on Day 3 of the treatment, as well as lower neutrophil levels in the blood on the day of the completion of antibacterial therapy in comparison with the control group. Conclusion. iNO at a dose of 200 ppm 3 times a day in patients with nosocomial pneumonia following cardiac surgical procedures is safe, leads to a reduction in the duration of antibacterial therapy, a decrease in the frequency of changes in antibacterial therapy regimens, the improvement of oxygenation, and faster changes in the laboratory markers of inflammation. The data obtained serve as a prerequisite for the use of iNO for the treatment of nosocomial pneumonia in cardiac surgical patients.

25 November 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TKT. P. Kalashnikova
T. P. Kalashnikova
YPYu. K. Podoksenov
Yu. K. Podoksenov
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
YAYu. A. Arsenyeva
Yu. A. Arsenyeva
MGM. B. Gorchakova
M. B. Gorchakova
ABAlla Boshchenko
Alla Boshchenko
Aim. To study the prevalence and risk factors (RF) for hospital-acquired pneumonia (HAP) after on-pump cardiac surgery in a modern cohort of patients.Material and methods. This retrospective analysis of the medical records of cardiovascular surgery patients, operated on in the period from January 1, 2022 to December 31, 2022. The study consistently included 417 patients who underwent on-pump cardiac surgery. The incidence and timing of HAP development were assessed. The influence of the main demographic, clinical, and perioperative factors on HAP risk was studied.Results. The pneumonia prevalence per year was 27,6%, including after the Frozen Elephant Trunk (FET) procedure — 32%, after coronary artery bypass grafting (CABG) — 29,5%, after combined CABG and heart valve surgery — 26,2%, after isolated valve surgery — 25,9%, after thoracic aortic hemiarch replacement — 19,5%. Pneumonia developed on the 4,6±2,9 day after surgery. The risk of pneumonia increased with atrial fibrillation (AF) before surgery (odds ratio (OR) 3,17; 95% confidence interval (CI): 1,67; 6,02, p=0,0002), on-pump duration (OR 1,01; 95% CI: 1,00; 1,01; p=0,0006), aortic cross-clamping (OR 1,01; 95% CI: 1,00; 1,01; p=0,0002) and mechanical ventilation (OR 1,03; 95% CI: 1,01; 1,05; p=0,005). Pneumonia predictors were on-pump duration ≥96 min (sensitivity 67,7%, specificity 64,6%, AUC=0,681, p=0,0006) and mechanical ventilation ≥14 h (sensitivity 63,1%, specificity 69,3%, AUC=0,641, p=0,005), as well as preoperative AF (sensitivity 61%, specificity 75%, p=0,0002).Conclusion. Preoperative AF, on-pump duration ≥96 min and mechanical ventilation ≥14 h serve as categorical and quantitative predictors of postoperative HAP in a modern cohort of patients.